Skip to main content
. 2017 Jul 22;40(10):855–869. doi: 10.1007/s40264-017-0572-8

Fig. 4.

Fig. 4

Continuum of the European Union pharmacovigilance system from pre- to post-marketing. ADR adverse drug reaction